Related Experiment Video
Updated: Dec 20, 2025
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Nadin Younes1, Duaa W Al-Sadeq1,2, Hadeel Al-Jighefee1
1Biomedical Research Center, Qatar University, P.O. Box 2713 Doha, Qatar.
Insights
Accurate COVID-19 diagnostics are crucial for pandemic control. While real-time PCR is standard, gaps remain in detecting asymptomatic cases and viral shedding, necessitating improved surveillance and testing strategies.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted the critical need for effective diagnostic tools.
- Previous coronavirus outbreaks underscore the importance of rapid and accurate diagnostics for pandemic containment.
- Current diagnostic methods face challenges in identifying asymptomatic infections and determining viral shedding duration.
Purpose of the Study:
- To review current laboratory methods and surveillance technologies for COVID-19 detection.
- To analyze the performance characteristics of existing diagnostic assays.
- To identify gaps in current diagnostic capacity and propose potential solutions.
Main Methods:
- Review of scientific literature on COVID-19 diagnostic methods.
- Analysis of performance data for real-time reverse transcriptase-polymerase chain reaction (rRT-PCR), point-of-care (POC) tests, and serologic immunoassays.
- Summary of specifications for commercially available COVID-19 diagnostic kits.
Main Results:
- Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) remains the gold standard for symptomatic patients.
- Emerging point-of-care (POC) and serologic immunoassays show high sensitivity and specificity.
- Significant gaps exist in screening asymptomatic individuals and assessing live viral shedding during convalescence.
Conclusions:
- Continued development of sensitive and specific diagnostic tools is essential for managing COVID-19.
- Addressing diagnostic limitations in asymptomatic and convalescent populations is crucial for effective public health strategies.
- A comprehensive approach integrating surveillance, diagnostics, and treatment is necessary to combat the pandemic.
Abstract:
The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.
